Clone Search


Resources for

Clontech Laboratories, Inc. and RIKEN BioResource Research Center concluded license agreement on preservation and distribution of Fluorescent Proteins, DsRed2 and mCherry for academic use

Clones & Vectors for Gene Expression
  Promoter collection
  Epitope tag fusion clones
  SEREX cDNA clone
  HLA antigen cDNA clone
  Nakamura & White RFLP clone

Resources for Gene Analysis
  Cultured microbe
  Cultured animal cell
  Experimental animal
  in vitro experiment
  Plant gene resources

Clone Set & Library
  Genomic clone
  cDNA clone
  Expression clone

Recombinant Virus
  Recombinant Adenovirus
  Shuttle Vector for Recombinant Virus

Genomic DNA
  JCM Microbial Genomic DNA
  BRC Mouse Genomic DNA

Search for resources
  Key word search
  Depositors List
  Gene Set Collection

BRC News

Life Technologies Corporation signs license agreement with RIKEN BRC (2009.11.03)


  • The Life Technologies Corporation (former Invitrogen IP Holdings, Inc.) and RIKEN BRC have signed a license agreement on July 2, 2009. With generosity of Life Technologies Corporation, Riken BRC is now able to receive, maintain, replicate and distribute GatewayR Entry clones and Expression clones for not-for-profit academic research under this agreement.
  • The Entry clone harboring cDNA can be distributed for not-for-profit academic research without any license fees. The Expression clone harboring mammalian cDNA can be distributed from the RIKEN BRC for not-for-profit academic research with a small amount of license fee to the Life Technologies Corporation. In addition to the regular fee for a cDNA clone, users are asked to pay RIKEN BRC 1,250 YEN per clone that includes the license fee, handling of currency exchange, money transfer and other expense. Every six months, RIKEN BRC will report to Life Technologies Corporation a number of distributions of Entry and Expression clones and send a sum of license fee for Expression clones. Any commercial users of the GatewayR Entry or Expression clones must contact Life Technologies Corporation for prior written approval.
  • RIKEN BRC has set the Material Transfer Agreements (MTA) for each transfer to protect the intellectual property rights of developers of bioresources and to define the responsibility of users. We have opened a path of the not-for-profit academic use of bioresources produced by using research tools owned by commercial entities.
  • Deposition of bioresources to the RIKEN BRC frees researchers from cumbersome preservation and distribution of materials fellow researchers. Furthermore, deposition increases chance of collaboration and citation of research paper. Your deposition of genetic resources in particular the GatewayR clones to the Gene Engineering Division is most appreciated.


(T.M. 2009.11.03)